艾迪药业 (688488.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

63.9x

Market Cap

CNY 6.70B

MomentumView details →

1D Return

−3.40%

YTD Return

—

RSI (14)

44.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

63.9x

Market Cap

CNY 6.70B

RSI (14)

44.1

MomentumView details →

1D Return

−3.40%

YTD Return

—

ProfitabilityView details →

Gross Margin

68.32%

Net Margin

−3.93%

EBITDA Margin

15.16%

ROE (TTM)

−2.82%

ROA (TTM)

−1.34%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+33.77%

EPS YoY

+72.45%

FCF YoY

—

Revenue CAGR 3Y

+43.33%

EPS CAGR 3Y

+85.29%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

1.50x

Quick Ratio

1.12x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

699.33M

Net Income (TTM)

−27.51M

Op. CF (TTM)

−21.23M

Latest newsMore news →

Aide Pharmaceutical announced its first-half 2026 results with revenue of 366 million yuan, up 0.93% year-on-year, and net profit attributable to shareholders of 22.93 million yuan, up 149.53% year-on-year.7d ago

Fu Hexiang, a person acting in concert with the actual controller of Aidea Pharmaceutical, pledged 4.5 million shares of the company to Shenzhen Shendan Credit Enhancement Financing Guarantee Co., Ltd. on August 17, 2026, for personal funding needs.17d ago

Similar companies

Arcellx, Inc.ACLX 昊海生科688366.SH Scholar Rock Holding CorporationSRRK CG Oncology, Inc. Common stockCGON 奥翔药业603229.SH Mirum Pharmaceuticals, Inc.MIRM Find similar companies →

Latest newsMore news →

Aide Pharmaceutical announced its first-half 2026 results with revenue of 366 million yuan, up 0.93% year-on-year, and net profit attributable to shareholders of 22.93 million yuan, up 149.53% year-on-year.7d ago Fu Hexiang, a person acting in concert with the actual controller of Aidea Pharmaceutical, pledged 4.5 million shares of the company to Shenzhen Shendan Credit Enhancement Financing Guarantee Co., Ltd. on August 17, 2026, for personal funding needs.17d ago